Worth reading
51Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Neutral
Direction inferred from the company’s description.Scale
—
Displayed only when the document provides numerical figures.Wording
Conditional
How definitive the wording is.Announced details
セラミド含有リポナノカプセル
Applicable field (uses covered by this announcement)
薬剤や有効成分の担持・運搬、環境に応答した放出
Launch date令和7年7月22日～23日（研究発表の開催期間・実績）
Relationship between the counterparty and the company
IVY COSMETICS CORPORATION4918
Relationship with the Company
Joint Research
CounterpartyKeio University
Impact on Business Performance
At this time, there is no impact on results for the current fiscal year
The company does not address Contract Value / Offering price.
Source (materials cited by the company)
第54回医用高分子シンポジウム
| Item | Details |
|---|---|
| Names of Products / Services Covered | セラミド含有リポナノカプセル |
| Counterparty | Keio University |
| Relationship with the Company | Joint Research |
| Launch date | 令和7年7月22日～23日（研究発表の開催期間・実績） |
| Applicable area | 薬剤や有効成分の担持・運搬、環境に応答した放出 |
| Impact on Business Performance | At this time, there is no impact on results for the current fiscal year |
| Source | 第54回医用高分子シンポジウム |
Items this document does not state (11)
Counterparty overviewContract ValueOffering priceContract DateAward/certification nameAwarding / certifying bodyRegistration number and expiry dateLocationLocation scaleQuantitative EffectsUsage history
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.第54回医用高分子シンポジウムで研究発表を行ったため。作製したリポナノカプセルには、多様な物質の担持能と酵素の至適条件に基づく分解特性があると説明されています。
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.